Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy
Phase 2
Not yet recruiting
- Conditions
- Diabetic Peripheral Neuropathy
- First Posted Date
- 2025-06-19
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT07028528
- Locations
- 🇦🇺
RDC Clinical, Fortitude Valley, Queensland, Australia
M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis
Phase 2
Recruiting
- Conditions
- Allergic Rhinitis Due to Grass Pollens
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 20
- Registration Number
- NCT06907680
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
CaroRite™ for Skin Health and Signs of Ageing
Phase 4
Recruiting
- Conditions
- Healthy VolunteerSkin ConditionAgeing Signs
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT06878001
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
OEA and LipiSperse Metabolic Study
Phase 4
Recruiting
- Conditions
- Healthy Volunteers - Male and FemalePharmacokinetic Study in Healthy Volunteers
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06840080
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases
Phase 3
Recruiting
- Conditions
- Healthy VolunteerImmune Response
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 220
- Registration Number
- NCT06837961
- Locations
- 🇦🇺
Griffith University, Southport, Queensland, Australia
LC-Plasma for Preventing URTIs and Reducing Symptoms
Phase 3
Recruiting
- Conditions
- Healthy VolunteerURTI
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 650
- Registration Number
- NCT06827327
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
Long-Term PEA Safety Study
Phase 2
Recruiting
- Conditions
- HealthySafety
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT06717867
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA
Phase 4
Not yet recruiting
- Conditions
- Optimal Absorption of Omega-3Healthy
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT06629103
- Locations
- 🇦🇺
RDC Clinical, Brisbane, Queensland, Australia
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Phase 3
Recruiting
- Conditions
- MobilityJoint PainChronic InflammationMuscle Pain
- Interventions
- Drug: Maolactin
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06444763
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia
Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults
Phase 3
Recruiting
- Conditions
- Circulatory; Change
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- RDC Clinical Pty Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT06440252
- Locations
- 🇦🇺
RDC Clinical Pty Ltd, Brisbane, Queensland, Australia